Samah Alimam, MBChB (Hons)

Clinical and molecular characterization of Myeloproliferative Neoplasms in Adolescent and Younger Adult Patients (>16 and <40 years) compared to patients aged over 40 years

MPNs are typically diagnosed in patients around 60-years old; therefore, scientific knowledge about MPN and changes in genetic codes are derived from patients around this age and data about younger patients is lacking. We will investigate younger patients who have developed an MPN and compare this with older individuals.